Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Resunab demonstrates clinical benefit in phase II trial in systemic sclerosis

Nov. 16, 2016

FDA awards orphan drug designation to ECCS-50 for scleroderma

Nov. 15, 2016

Medshine Discovery presents JAK2 inhibitors

Nov. 14, 2016

Mabion signs development and commercialization agreement with Mylan for Mabion-CD20

Nov. 10, 2016

ReVance Therapeutics initiates phase II trial of RT-002 in plantar fasciitis

Nov. 4, 2016

Mitsubishi Tanabe and Kolon Life Science sign licensing agreement for Invossa in Japan

Nov. 2, 2016

Flexion Therapeutics reports positive results from study of Zilretta in OA patients with diabetes

Nov. 2, 2016

AbbVie discloses TNF-alpha modulators

Nov. 2, 2016

AbbVie discloses novel TNF-alpha modulators

Oct. 31, 2016

FDA issues complete response letter for sarilumab for rheumatoid arthritis

Oct. 31, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...